ACTN4 wt Allele
Boehringer Ingelheim Advances Apecotrep to Phase 3 for Rare Kidney Disease FSGS Despite Mixed Mid-Stage Data
Boehringer Ingelheim; apecotrep; BI 764198; FSGS; Phase 3; Phase 2; proteinuria; TRPC6 inhibitor; kidney disease
Actionable Insights Powered by AI
Boehringer Ingelheim; apecotrep; BI 764198; FSGS; Phase 3; Phase 2; proteinuria; TRPC6 inhibitor; kidney disease